Skip to main content

Perimenopause Biomarker Tracking

Meaning

Perimenopause Biomarker Tracking is the systematic monitoring of specific hormonal and metabolic indicators during the transitional period leading up to menopause, which is characterized by fluctuating and declining ovarian function. Key biomarkers include Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), Estradiol (E2), and progesterone, alongside metabolic health indicators. This tracking provides an objective, longitudinal assessment of ovarian reserve and the rate of endocrine shift, enabling proactive clinical intervention to mitigate the often disruptive symptoms and long-term health risks associated with this transition.